Easy and effective ultrasound at the point of care

Easy and effective ultrasound at the point of care

Philips Lumify handheld ultrasound –
your tool in the fight against COVID-19

The evolving diagnostic needs of COVID-19 patients create uncertainty and stress for staff, equipment and budgets. Point-of care ultrasound has emerged as a particularly effective, flexible way to address these ever-changing challenges.

Philips Lumify is an economical, versatile, handheld point-of-care ultrasound solution for acquiring high-quality images that aid rapid decision-making. The solution is also easy to protect and quick to disinfect – making it an invaluable tool in the ongoing fight against COVID-19.

We're in this together

Request a demo to discover the potential of Philips Lumify in leading your fight against COVID-19

*

Contact information

* This field is mandatory

*
*
*
*
*
*
*
*
*

By specifying your reason for contact we will be able to provide you with a better service.

We work with partners and distributors who may contact you about this Philips product on our behalf.

*
*

Final CEE consent

Discover how Philips Lumify is helping
clinicians in the fight against COVID-19

Why choose Philips Lumify for
COVID-19-related point-of-care applications?

Lumify device

  • Its compact design fits in your pocket for quick diagnosis or rounds
  • The system is versatile, cost-effective and quick to disinfect
  • It offers built-in tools and protocols that support emergency, critical care and remote staff during point-of-care ultrasound acquisition
  • Reacts secure teleconsultation provides on-demand access to experts for real-time guidance to aid clinicians in performing diagnosis
  • Education offerings from leading ultrasound platform EMsono delivers one-on-one tele-ultrasound education using Lumify with Reacts

Learn more about the power of ultrasound in the fight against COVID-19

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.